Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review. - Wikidata - awgldk - TriplyDB

Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review.

Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review.

http://www.wikidata.org/entity/Q27687546

about

The Effect of a Combination Treatment Using Palonosetron, Promethazine, and Dexamethasone on the Prophylaxis of Postoperative Nausea and Vomiting and QTc Interval Duration in Patients Undergoing Craniotomy under General Anesthesia: A Pilot Study Performance associated effect variations of public reporting in promoting antibiotic prescribing practice: a cluster randomized-controlled trial in primary healthcare settings.Effects of palonosetron and ondansetron on preventing nausea and vomiting after laparoscopic surgery.

P2860

Q36527332-4256F6B5-21D4-4144-8B5F-8F07BE90566A Q40175778-5B2BEBED-3B89-4A13-92EB-85563B0AF0EF Q47272707-41BF2D89-9CB8-4318-97D7-00FB1822C2B5

P2860

Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review.

http://www.wikidata.org/entity/Q27687546

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Interventions to decrease the ...... agonists: a systematic review.

@ast

Interventions to decrease the ...... agonists: a systematic review.

@en

Interventions to decrease the ...... agonists: a systematic review.

@nl

type

label

Interventions to decrease the ...... agonists: a systematic review.

@ast

Interventions to decrease the ...... agonists: a systematic review.

@en

Interventions to decrease the ...... agonists: a systematic review.

@nl

prefLabel

Interventions to decrease the ...... agonists: a systematic review.

@ast

Interventions to decrease the ...... agonists: a systematic review.

@en

Interventions to decrease the ...... agonists: a systematic review.

@nl

P1433

Q27687546-9FBA82C9-F655-440A-81E8-B4305F20C7CF

P1476

Q27687546-49434653-4D52-42EC-AD5A-EA2A4D094B73

P2093

Q27687546-0FA93DC1-C82D-45CC-AD0F-05ED7870498B

Q27687546-2ACECEE0-7EC8-4227-AF1C-3E3176267140

Q27687546-566836DB-943E-4EF8-BAA7-6E4198F10F86

Q27687546-64857A2D-A713-4E0A-BD93-F1D4962186C3

Q27687546-9404FA70-7707-47F9-8CC5-26182FABDCA2

Q27687546-B857FC51-1D5F-43C4-B8E5-445D00661B37

Q27687546-DE3ACAC6-E124-4A24-AA98-661EA3DC9991

P275

Q27687546-9E6D116B-5370-42A1-8905-7383B6E28BBE

P2860

Q27687546-14673BA2-5EEC-4F20-93D9-83664BCF118D

Q27687546-18F04A01-38A8-4C0B-979D-9D4278EF081E

Q27687546-1FFA4EFA-30E2-4D72-99C8-2BCC7838EDDF

Q27687546-28CE9669-E782-493A-968B-26714A64CDF1

Q27687546-2B1F325C-543A-4EEE-B654-7F39F29CDCE4

Q27687546-49E3D061-763B-4A1B-ABEF-7ACD72CADED9

Q27687546-4CB123BE-E291-45A7-8F55-5EE46F3EA3A0

Q27687546-5B20F646-0EEE-4DAE-9135-2D4C143FA144

Q27687546-6612FF52-EE73-41BD-A189-DF15B9C0FFB7

Q27687546-67555ECC-13FE-4C7C-AF78-FA7F1CB7BFB2

P2888

Q27687546-1E759847-DCB7-413F-9621-D52633B6112A

P304

Q27687546-839B5258-1820-418F-A21A-3AB9BBF8EA11

P31

Q27687546-0DFE6538-D669-43A6-B18F-04650E5F1E9D

Q27687546-50BCFAAE-3B44-4D37-B5DE-44A92465FEBF

Q27687546-889F02EE-7E8E-4417-9C8C-24D2A3B5CAC7

P3181

Q27687546-7BD66633-8DE2-4F8B-ABA1-BBAB248B9BAF

P356

Q27687546-3383B164-2212-4C71-B219-3F0B8DE136E9

P478

Q27687546-A18C22B0-6DB3-4F6A-92E5-630E961EBD0D

P50

Q27687546-5B054DD2-8514-4E6F-88BE-266C64009362

Q27687546-95521D40-3670-4AEF-807E-53839645770B

P5008

Q27687546-01BB710A-E093-4FA6-86C8-EF71124B93AA

P577

Q27687546-59B43A7D-4C22-4905-9EA5-2D3E60843FCE

P5875

Q27687546-B2301996-87C1-4007-BB0B-5C75B5842B61

P6179

Q27687546-B402CDE6-A39A-43E7-841A-29002C798594

P698

Q27687546-EF5C5D98-697C-45B2-AA3D-B27B3EF0402F

P921

Q27687546-33E5603C-E404-4FEC-A1FB-3BDFAEEF0D67

Q27687546-595C0573-3BE4-4187-982E-7A613A61CFDD

Q27687546-BB78BD9E-E5DC-4730-8DD1-20C889F79C93

Q27687546-fb38233c-87c7-42ed-82a7-7ec0494648f4

P932

Q27687546-A4B1438A-0999-4D64-846F-0D432497E236

P3181

P356

P1433

BMC pharmacology & toxicology

P1476

Interventions to decrease the ...... agonists: a systematic review.

@en

P2093

Andrea C Tricco

http://www.w3.org/2001/XMLSchema#string

Brenda Hemmelgarn

http://www.w3.org/2001/XMLSchema#string

Brian Hutton

http://www.w3.org/2001/XMLSchema#string

Charlene Soobiah

http://www.w3.org/2001/XMLSchema#string

Jesmin Antony

http://www.w3.org/2001/XMLSchema#string

Vladi Struchkov

http://www.w3.org/2001/XMLSchema#string

Wing Hui

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

An evidence-based practice guideline for the peer review of electronic search strategies.

Open-label, randomized comparison of the efficacy of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed cisplatin-induced emesis in cancer patients.

A network meta-analysis on the efficacy of serotonin type 3 receptor antagonists used in adults during the first 24 hours for postoperative nausea and vomiting prophylaxis.

Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling.

Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis.

Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block

Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials.

Mechanisms of reducing postoperative pain, nausea and vomiting: a systematic review of current techniques.

Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.

P2888

P304

1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

4026675

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/2050-6511-16-1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Sharon E Straus

P5008

P577

2015-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271594779

http://www.w3.org/2001/XMLSchema#string

P6179

1046693780

http://www.w3.org/2001/XMLSchema#string

P698

25623303

http://www.w3.org/2001/XMLSchema#string

P921

heart arrhythmia

mechanism of action

P932

4417335

http://www.w3.org/2001/XMLSchema#string